November 2017

NCI Helps Children’s Hospital of Philadelphia to Identify and Treat New Target in Pediatric Cancer

There may be a new, more effective method for treating high-risk neuroblastoma, according to scientists at the Children’s Hospital of Philadelphia and collaborators in the Cancer and Inflammation Program at NCI at Frederick. Together, the groups published a study describing a previously unrecognized protein on neuroblastoma cells, called GPC2, as well as the creation of a novel antibody-drug conjugate, a combination of a human antibody and a naturally occurring anticancer drug, that locates and binds to GPC2 in a highly efficient way.

Building 549 Becomes the Backdrop for an Updated Mural

Next time you walk through Building 549 at the National Cancer Institute at Frederick campus, make sure you check out the bright new mural adorning the walls outside the auditorium. A collaboration between the Office of Scientific Operations and Scientific Publications, Graphics and Media, the mural evokes the goals and efforts of the Frederick National Lab and NCI at Frederick.